spacer
spacer

PDBsum entry 1pk5

Go to PDB code: 
protein Protein-protein interface(s) links
Gene regulation PDB id
1pk5

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
242 a.a. *
Waters ×158
* Residue conservation analysis
PDB id:
1pk5
Name: Gene regulation
Title: Crystal structure of the orphan nuclear receptor lrh-1
Structure: Orphan nuclear receptor nr5a2. Chain: a, b. Fragment: lrh-1 lbd. Synonym: liver receptor homolog, lrh-1. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Gene: nr5a2 or lrh1. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.40Å     R-factor:   0.208     R-free:   0.235
Authors: E.P.Sablin,I.N.Krylova,R.J.Fletterick,H.A.Ingraham
Key ref:
E.P.Sablin et al. (2003). Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell, 11, 1575-1585. PubMed id: 12820970 DOI: 10.1016/S1097-2765(03)00236-3
Date:
04-Jun-03     Release date:   01-Jul-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P45448  (NR5A2_MOUSE) -  Nuclear receptor subfamily 5 group A member 2 from Mus musculus
Seq:
Struc:
 
Seq:
Struc:
560 a.a.
242 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 

 
DOI no: 10.1016/S1097-2765(03)00236-3 Mol Cell 11:1575-1585 (2003)
PubMed id: 12820970  
 
 
Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1.
E.P.Sablin, I.N.Krylova, R.J.Fletterick, H.A.Ingraham.
 
  ABSTRACT  
 
The orphan nuclear receptors SF-1 and LRH-1 are constitutively active, but it remains uncertain whether their activation is hormone dependent. We report the crystal structure of the LRH-1 ligand binding domain to 2.4 A resolution and find the receptor to be a monomer that adopts an active conformation with a large but empty hydrophobic pocket. Adding bulky side chains into this pocket resulted in full or greater activity suggesting that, while LRH-1 could accommodate potential ligands, these are dispensable for basal activity. Constitutive LRH-1 activity appears to be conferred by a distinct structural element consisting of an extended helix 2 that provides an additional layer to the canonical LBD fold. Mutating the conserved arginine in helix 2 reduced LRH-1 receptor activity and coregulator recruitment, consistent with the partial loss-of-function phenotype exhibited by an analogous SF-1 human mutant. These findings illustrate an alternative structural strategy for nuclear receptor stabilization in the absence of ligand binding.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Structure of LRH-1 Ligand Binding Domain(A and B) Ribbon representation of LRH-1 structure shows α helices and β strands forming four layers in the LRH-1 structure as highlighted with orange, purple, pink, and red, respectively. The view on (B) is rotated vert, similar 90° relative to that shown in (A). The LRH-1 specific helix H2 (red) forms the fourth and outmost layer in the structure.(C) Superposition of LRH-1 with the RXRα LBD bound to ligand (PDB entry 1FBY) depicts LRH-1 in orange and RXRa with 9-cis-retinoic acid in blue.
Figure 6.
Figure 6. The Role of Helix H2 in Stabilizing and Activating LRH-1(A) Residues at the interface between helix H2 and H3 are indicated, and those that are conserved between LRH-1 and SF-1 are underlined. The position of the conserved arginine R352 that is mutated in the SF-1 R255L human patient is circled.(B) Activity of wild-type LRH-1 (black bars) or the R352E mutant (gray bars) was measured using the AroLuc reporter in HepG2 cells, with or without increasing concentrations of mouse corepressor SHP (+SHP) or the coactivator human GRIP1 (+GRIP).
 
  The above figures are reprinted by permission from Cell Press: Mol Cell (2003, 11, 1575-1585) copyright 2003.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22504882 P.M.Musille, M.C.Pathak, J.L.Lauer, W.H.Hudson, P.R.Griffin, and E.A.Ortlund (2012).
Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.
  Nat Struct Mol Biol, 19, 532.
PDB codes: 4dor 4dos
20853131 F.M.Yang, Y.C.Lin, and M.C.Hu (2011).
Identification of two functional nuclear localization signals mediating nuclear import of liver receptor homologue-1.
  Cell Mol Life Sci, 68, 1241-1253.  
20096661 J.C.Heng, B.Feng, J.Han, J.Jiang, P.Kraus, J.H.Ng, Y.L.Orlov, M.Huss, L.Yang, T.Lufkin, B.Lim, and H.H.Ng (2010).
The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
  Cell Stem Cell, 6, 167-174.  
20723571 L.Jin, and Y.Li (2010).
Structural and functional insights into nuclear receptor signaling.
  Adv Drug Deliv Rev, 62, 1218-1226.  
20460755 M.Ohno, J.Komakine, E.Suzuki, M.Nishizuka, S.Osada, and M.Imagawa (2010).
Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins.
  Biol Pharm Bull, 33, 784-791.  
20372994 S.Mukherjee, and S.Mani (2010).
Orphan nuclear receptors as targets for drug development.
  Pharm Res, 27, 1439-1468.  
19250199 S.E.Bulun, Z.Lin, H.Zhao, M.Lu, S.Amin, S.Reierstad, and D.Chen (2009).
Regulation of aromatase expression in breast cancer tissue.
  Ann N Y Acad Sci, 1155, 121-131.  
19015525 E.P.Sablin, A.Woods, I.N.Krylova, P.Hwang, H.A.Ingraham, and R.J.Fletterick (2008).
The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1.
  Proc Natl Acad Sci U S A, 105, 18390-18395.
PDB code: 3f5c
18798693 S.W.Kruse, K.Suino-Powell, X.E.Zhou, J.E.Kretschman, R.Reynolds, C.Vonrhein, Y.Xu, L.Wang, S.Y.Tsai, M.J.Tsai, and H.E.Xu (2008).
Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor.
  PLoS Biol, 6, e227.
PDB code: 3cjw
17910058 T.Zhang, J.H.Zhou, L.W.Shi, R.X.Zhu, and M.B.Chen (2008).
Molecular dynamics simulation study for LRH-1: interaction with fragments of SHP and function of phospholipid ligand.
  Proteins, 70, 1527-1539.  
17908794 C.Mataki, B.C.Magnier, S.M.Houten, J.S.Annicotte, C.Argmann, C.Thomas, H.Overmars, W.Kulik, D.Metzger, J.Auwerx, and K.Schoonjans (2007).
Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1.
  Mol Cell Biol, 27, 8330-8339.  
16317770 S.A.Khan, S.W.Park, M.D.Huq, and L.N.Wei (2006).
Ligand-independent orphan receptor TR2 activation by phosphorylation at the DNA-binding domain.
  Proteomics, 6, 123-130.  
16439367 Y.K.Lee, Y.H.Choi, S.Chua, Y.J.Park, and D.D.Moore (2006).
Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation.
  J Biol Chem, 281, 7850-7855.  
15923626 A.Chalkiadaki, and I.Talianidis (2005).
SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.
  Mol Cell Biol, 25, 5095-5105.  
15616833 B.Windshügel, J.Jyrkkärinne, A.Poso, P.Honkakoski, and W.Sippl (2005).
Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity.
  J Mol Model, 11, 69-79.  
16054039 D.D.Moore (2005).
CAR: three new models for a problem child.
  Cell Metab, 1, 6-8.  
15723037 E.A.Ortlund, Y.Lee, I.H.Solomon, J.M.Hager, R.Safi, Y.Choi, Z.Guan, A.Tripathy, C.R.Raetz, D.P.McDonnell, D.D.Moore, and M.R.Redinbo (2005).
Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.
  Nat Struct Mol Biol, 12, 357-363.
PDB code: 1yuc
15888456 F.Molnár, M.Matilainen, and C.Carlberg (2005).
Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
  J Biol Chem, 280, 26543-26556.  
15707893 I.N.Krylova, E.P.Sablin, J.Moore, R.X.Xu, G.M.Waitt, J.A.MacKay, D.Juzumiene, J.M.Bynum, K.Madauss, V.Montana, L.Lebedeva, M.Suzawa, J.D.Williams, S.P.Williams, R.K.Guy, J.W.Thornton, R.J.Fletterick, T.M.Willson, and H.A.Ingraham (2005).
Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.
  Cell, 120, 343-355.
PDB codes: 1ymt 1yok 1yow
15572376 J.Jyrkkärinne, B.Windshügel, J.Mäkinen, M.Ylisirniö, M.Peräkylä, A.Poso, W.Sippl, and P.Honkakoski (2005).
Amino acids important for ligand specificity of the human constitutive androstane receptor.
  J Biol Chem, 280, 5960-5971.  
15933191 J.P.Changeux, and S.J.Edelstein (2005).
Allosteric mechanisms of signal transduction.
  Science, 308, 1424-1428.  
16091743 J.S.Annicotte, C.Chavey, N.Servant, J.Teyssier, A.Bardin, A.Licznar, E.Badia, P.Pujol, F.Vignon, T.Maudelonde, G.Lazennec, V.Cavailles, and L.Fajas (2005).
The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.
  Oncogene, 24, 8167-8175.  
15684064 K.Schoonjans, L.Dubuquoy, J.Mebis, E.Fayard, O.Wendling, C.Haby, K.Geboes, and J.Auwerx (2005).
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation.
  Proc Natl Acad Sci U S A, 102, 2058-2062.  
15709961 K.W.Nettles, and G.L.Greene (2005).
Ligand control of coregulator recruitment to nuclear receptors.
  Annu Rev Physiol, 67, 309-333.  
15713642 M.B.Lee, L.A.Lebedeva, M.Suzawa, S.A.Wadekar, M.Desclozeaux, and H.A.Ingraham (2005).
The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
  Mol Cell Biol, 25, 1879-1890.  
15858847 R.G.Tirona, and R.B.Kim (2005).
Nuclear receptors and drug disposition gene regulation.
  J Pharm Sci, 94, 1169-1186.  
16054837 T.Balla (2005).
Found in the crystal: phospholipid ligands for nuclear orphan receptors.
  Trends Endocrinol Metab, 16, 289-290.  
15897460 W.Wang, C.Zhang, A.Marimuthu, H.I.Krupka, M.Tabrizizad, R.Shelloe, U.Mehra, K.Eng, H.Nguyen, C.Settachatgul, B.Powell, M.V.Milburn, and B.L.West (2005).
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1.
  Proc Natl Acad Sci U S A, 102, 7505-7510.
PDB codes: 1zdt 1zdu
15976031 Y.Li, M.Choi, K.Suino, A.Kovach, J.Daugherty, S.A.Kliewer, and H.E.Xu (2005).
Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner.
  Proc Natl Acad Sci U S A, 102, 9505-9510.
PDB codes: 1zgy 1zh7
15456745 A.Codina, G.Benoit, J.T.Gooch, D.Neuhaus, T.Perlmann, and J.W.Schwabe (2004).
Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting.
  J Biol Chem, 279, 53338-53345.  
15151997 C.Frank, F.Molnár, M.Matilainen, H.Lempiäinen, and C.Carlberg (2004).
Agonist-dependent and agonist-independent transactivations of the human constitutive androstane receptor are modulated by specific amino acid pairs.
  J Biol Chem, 279, 33558-33566.  
15130581 E.Fayard, J.Auwerx, and K.Schoonjans (2004).
LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.
  Trends Cell Biol, 14, 250-260.  
15246430 G.Benoit, M.Malewicz, and T.Perlmann (2004).
Digging deep into the pockets of orphan nuclear receptors: insights from structural studies.
  Trends Cell Biol, 14, 369-376.  
15143342 K.R.Steffensen, E.Holter, A.Båvner, M.Nilsson, M.Pelto-Huikko, S.Tomarev, and E.Treuter (2004).
Functional conservation of interactions between a homeodomain cofactor and a mammalian FTZ-F1 homologue.
  EMBO Rep, 5, 613-619.  
15610733 K.Suino, L.Peng, R.Reynolds, Y.Li, J.Y.Cha, J.J.Repa, S.A.Kliewer, and H.E.Xu (2004).
The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.
  Mol Cell, 16, 893-905.
PDB code: 1xls
15327767 O.A.Botrugno, E.Fayard, J.S.Annicotte, C.Haby, T.Brennan, O.Wendling, T.Tanaka, T.Kodama, W.Thomas, J.Auwerx, and K.Schoonjans (2004).
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.
  Mol Cell, 15, 499-509.  
15350600 P.J.Fuller, B.J.Smith, and F.M.Rogerson (2004).
Cortisol resistance in the New World revisited.
  Trends Endocrinol Metab, 15, 296-299.  
12842037 Y.Li, M.H.Lambert, and H.E.Xu (2003).
Activation of nuclear receptors: a perspective from structural genomics.
  Structure, 11, 741-746.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer